One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience.


Journal

Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 15 12 2021
accepted: 24 12 2021
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 5 4 2022
Statut: epublish

Résumé

In the early months of the coronavirus disease 2019 (COVID-19) pandemic, our center reported a mortality rate of 34% in a cohort of 32 lung transplant recipients with COVID-19 between March and May 2020. Since then, there has been evolving knowledge in prevention and treatments of COVID-19. To evaluate the impact of these changes, we describe the clinical presentation, management, and outcomes of a more recent cohort of lung transplant recipients during the second surge and provide a comparison with our first cohort. We conducted a retrospective cohort study that included all consecutive lung transplant recipients who tested positive for severe acute respiratory syndrome coronavirus 2 between November 2020 and February 28, 2021. We compared baseline demographics and major outcomes between the first- and second-surge cohorts. We identified 47 lung transplant recipients (median age, 60; 51% female) who tested positive for severe acute respiratory syndrome coronavirus 2 between November 2020 and February 28, 2021. The current cohort had a higher proportion of patients with mild disease (34% versus 16%) and fewer patients with a history of obesity (4% versus 25%). Sixty-six percent (n = 31) required hospitalization and were treated with remdesivir (90%) and dexamethasone (84%). Among those hospitalized, 77% (n = 24) required supplemental oxygen, and 22% (n = 7) required invasive mechanical ventilation. The overall 90-d mortality decreased from 34% to 17% from the first cohort to the second (adjusted odds ratio, 0.26; 95% confidence interval, 0.08-0.85; Although COVID-19-associated mortality rate in lung transplant recipients at our center has decreased over time, COVID-19 continues to be associated with significant morbidity and mortality.

Identifiants

pubmed: 35368985
doi: 10.1097/TXD.0000000000001296
pmc: PMC8966964
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e1296

Informations de copyright

Copyright © 2022 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors declare no funding or conflicts of interest.

Références

Am J Respir Crit Care Med. 2021 Mar 1;203(5):565-574
pubmed: 33306946
Transplantation. 2020 Nov;104(11):2208-2214
pubmed: 32496357
J Hosp Med. 2021 Feb;16(2):90-92
pubmed: 33147129
Transplantation. 2021 Jan 1;105(1):128-137
pubmed: 32890139
Am J Transplant. 2021 May;21(5):1816-1824
pubmed: 33089648
Clin Infect Dis. 2021 Jan 27;72(2):340-350
pubmed: 33501974
Ann Intern Med. 2021 Sep;174(9):1240-1251
pubmed: 34224257
Clin Infect Dis. 2021 Dec 6;73(11):e4090-e4099
pubmed: 32766815
Am J Transplant. 2021 May;21(5):1825-1837
pubmed: 33098200
Am J Transplant. 2020 Nov;20(11):3225-3233
pubmed: 32476258
Transplantation. 2021 Sep 1;105(9):2072-2079
pubmed: 34075005
J Heart Lung Transplant. 2021 Sep;40(9):936-947
pubmed: 34172387
Transplantation. 2021 Jun 1;105(6):1365-1371
pubmed: 33988341
Mil Med Res. 2020 Sep 4;7(1):41
pubmed: 32887670
Ann Intern Med. 2021 May;174(5):613-621
pubmed: 33460330
Transpl Infect Dis. 2021 Aug;23(4):e13595
pubmed: 33641202
J Gen Intern Med. 2020 Nov;35(11):3308-3314
pubmed: 32885373
Am J Transplant. 2020 Nov;20(11):3051-3060
pubmed: 32654332
N Engl J Med. 2020 Jun 18;382(25):2475-2477
pubmed: 32329975
Transplant Proc. 2021 May;53(4):1180-1186
pubmed: 33419577
Transpl Int. 2020 Sep;33(9):1099-1105
pubmed: 32460390
Transplant Rev (Orlando). 2021 Jan;35(1):100588
pubmed: 33246166
Open Forum Infect Dis. 2020 Nov 09;7(11):ofaa528
pubmed: 33274249
Am J Transplant. 2020 Nov;20(11):3162-3172
pubmed: 32777130
Transplantation. 2021 Jul 1;105(7):1433-1444
pubmed: 33988335
JAMA Intern Med. 2021 Apr 1;181(4):471-478
pubmed: 33351068
Am J Transplant. 2020 Nov;20(11):3072-3080
pubmed: 32881315
Transpl Infect Dis. 2020 Dec;22(6):e13364
pubmed: 32521074
Crit Care Med. 2020 Dec;48(12):e1382-e1384
pubmed: 32991356
Transpl Infect Dis. 2021 Aug;23(4):e13637
pubmed: 33993630
Transplantation. 2021 Jan 1;105(1):177-186
pubmed: 33141808
Nature. 2020 Nov;587(7833):190-192
pubmed: 33177662

Auteurs

Kemarut Laothamatas (K)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.

Jamie Hum (J)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Luke Benvenuto (L)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Lori Shah (L)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Harpreet Singh Grewal (HS)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Marcus Pereira (M)

Division of Infectious Disease, Department of Medicine, Columbia University Irving Medical Center, New York, NY.

Jenna Scheffert (J)

Department of Pharmacy, New York-Presbyterian Hospital, New York, NY.

Maggie Carroll (M)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Margaret Nolan (M)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Genevieve Reilly (G)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Philippe Lemaitre (P)

Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.
Section of Thoracic Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY.

Bryan P Stanifer (BP)

Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.
Section of Thoracic Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY.

Joshua R Sonett (JR)

Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.
Section of Thoracic Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY.

Frank D'Ovidio (F)

Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.
Section of Thoracic Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY.

Hilary Robbins (H)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Selim M Arcasoy (SM)

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
Department of Pulmonary, Allergy, and Critical Care Medicine, Lung Transplant Program, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, NY.

Classifications MeSH